Clinical Trial Update: A Study Assessing the Safety and Efficacy of Sarilumab Added to Non-MTX DMARDs or as Monotherapy in Japanese Patients With Active Rheumatoid Arthritis (SARIL-RA-HARUKA) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial in Japanese patients with active rheumatoid arthritis assessed adding sarilumab to non-MTX DMARDs or as monotherapy; completed with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Sarilumab (sarilumab)

Snippet

Sponsor: Sanofi | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2018-01-30